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Abstract
Background: Inflammatory myofibroblastic tumor (IMT) is a neoplasm of unknown etiology
occurring at various sites. By definition, it is composed of spindle cells (myofibroblasts) with
variable inflammatory component, hence the name is IMT.
Case presentation: The present case is of a 46 years old woman presented with a history of flank
pain, abdominal mass and intermittent hematuria for last 6 months. The initial diagnosis was kept
as renal cell carcinoma. Finally, it turned out to be a case of retroperitoneal IMT. The patient was
managed by complete surgical resection of the tumor.
Conclusion: IMT is a rare neoplasm of uncertain biological potential. Complete surgical resection
remains the mainstay of the treatment.
Introduction
Inflammatory myofibroblastic tumor (IMT) is a relatively
rare neoplasm. The outlook of this disease has changed
with time from a benign reactive process to a malignant
neoplasm, based on the multiple case reports demonstrat-
ing recurrent and constant clonal genetic alterations [1-5].
There are three main histological patterns: nodular fascii-
tis-like, fibrous histiocytoma-like, and desmoid or scar tis-
sue-type. Though morphologically similar, they
encompass a spectrum of entities with varied etiology,
ranging from reactive/regenerative proliferations to low-
grade neoplasms with a risk of local recurrence, and met-
astatic potential [3]. The commonest site of IMT is lung
with a few case reports from extra pulmonary sites [6]. In
the genitourinary tract, it most commonly occurs in the
bladder. However it rarely originates in the kidney, renal
pelvis, and ureter [4]. In the English literature only six
cases of retroperitoneal IMT were reported [6-8]
Case presentation
A 46-years-old woman presented with history of flank
pain, abdominal lump and intermittent hematuria of 6
months duration. She was diagnosed as renal cell carci-
noma (RCC) elsewhere and referred. The investigations at
our hospital revealed normal hematological and bio-
chemical parameters. The urine microscopy showed
deformed RBC. The computerized tomography (CT) scan
of the abdomen showed a large irregular well defined het-
erogeneous lesion occupying the left hypochondrium,
lumbar and supra umbilical regions, measuring
approximately 16 × 13.6 × 12.1 cm, and showed presence
of predominant cystic portions with no obvious
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calcifications (figure 1 &2). The mass was contiguously
involving the upper half of the kidney. Fine needle aspira-
tion cytology (FNAC) of the mass was suggestive of sarco-
matoid renal cell carcinoma. The metastatic work-up
including bone scan, and CT scan of the thorax were
essentially normal. With a provisional diagnosis of renal
cell carcinoma surgery was planned. Intra operatively a
huge mass was observed in the retroperitoneal region aris-
ing from the left kidney and attempts to separate the mass
from the kidney were unsuccessful. Hence, left nephrec-
tomy with adrenalectomy was performed with complete
excision of the tumor mass. Histopathology showed large
encapsulated mass 16 × 17 × 12 cm attached to kidney on
its posterior aspect. The tumor showed a predominantly
spindle cell pattern consisting of cellular fascicles showing
mild atypia, with a diffuse sprinkling of lymphocytes and
plasma cells and a few lymphoid aggregates. Only an
occasional mitosis was identified in these areas. Hypocel-
lular areas with sparse cells and a collagenous stroma were
also present. One area of the tumor showed features of
malignant transformation, with sheets of bi and multinu-
cleated and multilobed cells in a background of atypical
spindle cells with interspersed inflammatory cells (figure
3). Mitoses in this area were 3–4/high power field and
focal necrosis was present. Immunohistochemisty for
desmin, smooth muscle actin (SMA), epithelial mem-
brane antigen (EMA), cytokeratin (CK), CD68, HMB45
and ALK were performed. Desmin showed diffuse positiv-
ity, while SMA, EMA and CD68 showed focal positivity.
CK, HMB45 and ALK were negative. A diagnosis of
inflammatory myofibroblastic tumor with malignant
transformation was made.
CT abdomen of the patient showing large irregular heteroge- neous lesion measuring approximately 16 × 13.6 × 12.1 cm  with predominant cystic portions without calcifications Figure 1
CT abdomen of the patient showing large irregular heteroge-
neous lesion measuring approximately 16 × 13.6 × 12.1 cm 
with predominant cystic portions without calcifications.
contrast enhanced CT abdomen of the patient showing the  same lesion as in fig. 1 which is non enhancing Figure 2
contrast enhanced CT abdomen of the patient showing the 
same lesion as in fig. 1 which is non enhancing.
Spindle cells with interspersed lymphocytes and plasma cells Figure 3
Spindle cells with interspersed lymphocytes and plasma cells. 
Inset shows pleomorphic, multilobed tumor cells (Hematox-
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Page 3 of 4
(page number not for citation purposes)
Discussion
IMT is a relatively rare neoplasm. It was previously
referred as plasma cell granuloma, or inflammatory
pseudo tumor (IPT). It has long been debated regarding
the origin of IMT whether it was truly neoplastic or a post
inflammatory process. The proposed etiologies included
Epstein Barr virus (EBV), Human herpes virus (HHV8),
and over expression of interleukin IL-6. Though other dis-
eases like Kaposi's sarcoma and Castleman's diseases also
have similar etiologies, molecular transcription form of
open reading frame (ORF) -16, K13, 72 expressed in IMT
are not expressed in the aforesaid diseases [9]. Moreover
the recent research suggest that IMT is probably a neo-
plasm rather than a post-inflammatory process because of
cytogenetic clonality, recurrent involvement of chromo-
somal region 2p23, occasional aggressive local behavior
and metastasis of the tumor [1,2,4,5].
It is more common in children without sex predilection,
though extra pulmonary forms are more common in adult
females. The patients often present with fever of unknown
origin and other vague nonspecific symptoms. Usually it
has a benign course and in most of the cases it is a slow
growing, locally confined tumor with less metastatic
potential. However, there are some predictors for
aggressive behavior and metastatic potential of IMT which
include presence of ganglion like cells, cellular atypia,
aneuploidy, and p53 over expression [11,12].
The tumor commonly occurs in lung. Extra pulmonary
IMT are rare. In the largest series of 84 cases of extra pul-
monary IMT, only four retroperitoneal IMT were reported
[6] The medline search revealed only six cases of exclusive
retroperitoneal IMT (excluding renal and pancreatic IMT).
All the cases had flank pain as in our case. However hema-
turia which was observed in our case was found only in
one case [8]. Other common features like fever, weight
loss were not observed in our case. We initially
approached the case as renal cell carcinoma due to the
presence of classical triad of pain, lump and hematuria
along with typical CT scan findings, and to our surprise
the final diagnosis came as IMT. It would be possible on
frozen section to differentiate this tumor from renal cell
carcinoma. However the area showing malignant transfor-
mation could be confused with a sarcomatoid renal cell
carcinoma. It is also difficult on frozen section to differen-
tiate this tumor from an inflammatory process and this
difficulty would also apply to assessment of margins of
resection. So we feel that the total excision was more
appropriate as the tumor is known for more local recur-
rences than distant metastasis. Preoperative or intra
operative FNAC would be adequate to differentiate this
lesion from renal cell carcinoma. However if the pleomor-
phic area is sampled it could lead to confusion with a sar-
comatoid RCC. Therefore, avoiding of this situation is
difficult and whenever the suggestion is IMT, a complete
excision is advisable rather than going for organ preserv-
ing surgery.
Though IMT will not make its place in the common differ-
ential diagnosis of retroperitoneal masses, it should be
kept in mind as one of the possibilities. Typically the IMT
is characterized by the expression of vimentin, smooth
muscle actin, and cytokeratins, corresponded to that of
myofibroblasts along with other inflammatory markers
[10]. In the present case, the IHC is positive for EMA and
desmin, which are smooth muscle markers and CD-68 is
an inflammatory marker, suggesting the tumor to be IMT.
Little data is available in the management of IMT owing to
its rarity. Surgery remains the main stay of treatment.
Though radiotherapy [12], immunosuppression and
chemotherapy (cisplatin, doxorubicin & methotrexate)
[13] have been tried as an adjunct to surgery, however, no
definitive benefit was demonstrated by any of these
modalities [14]. In the present case as the tumor was
completely removed and the metastasis is rare in IMT, the
patient was offered no adjuvant therapy. The patient
remained asymptomatic even after 1 year of follow-up
without any evidence of disease. We expect long term sur-
vival in this case, as all the reported cases of retroperito-
neal IMT had long disease-free survival [8].
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